Project Grant HT94252510549
Award Date 11/1/25
Completion Date 10/31/28
Dollars Obligated $2.2M
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Tacoma, WA 98402, USA
Similar Awards
- The Geneva Foundation received a $4,676,544 Project Grant award from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420) to develop and validate innate immunome-targeted therapies to create a pro-survival and organ-protective phenotype after hemorrhage at the point of injury. Specifically, the Foundation will investigate immunotherapy approaches for hemorrhage treatments using innate immunome-targeted therapies from July 1, 2023 to...
- This federal Project Grant award, valued at $1,009,750.00, was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to The Geneva Foundation, a non-profit research organization based in Tacoma, Washington. The grant supports advanced biomedical research focused on the "Genomic and Functional Characterization of Chemoresistance in Small Cell Lung Cancer". The award period runs from August 1, 2025, to July 31, 2028. The Geneva...
- The Defense Health Agency awarded a $4,817,413 Project Grant to The Geneva Foundation on July 15, 2025 under the Military Medical Research and Development program (CFDA 12.420). The grant funds the development of a patient-matched segmental defect implant system with mechanobiologic activation and antimicrobial coating for the treatment of severe fractures. The 3-year project, scheduled for completion by July 14, 2028, aims to create an innovative medical solution that addresses critical...
- This federal Project Grant award of $487,800.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports research by The Geneva Foundation to define the cellular origins and molecular vulnerabilities of Notch-driven lymphomas. The project will run from October 1, 2025 to September 30, 2027 and is being conducted in Tacoma, Washington. The Geneva Foundation, a non-profit research organization, will lead this advanced biomedical research effort,...
- This $909,510 Project Grant award was made on May 1, 2025 by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to The Geneva Foundation, a non-profit medical research organization based in Tacoma, WA. The grant funding will support advanced biomedical research aimed at developing precision therapy approaches to eradicate brain metastatic breast cancer over the 3-year project period ending on April 30, 2028. The Geneva Foundation plans to...
- This federal Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) provides $1,065,392.00 to The Geneva Foundation to conduct research on "LOCAL SLEEP IN THE WAKING BRAIN: A NOVEL TARGET FOR COGNITIVE FATIGUE". The project period runs from June 1, 2024 to May 31, 2028. As a non-profit research organization, The Geneva Foundation will perform foundational biomedical research investigating innovative treatments for...
- This Project Grant award for $366,000.00, awarded on Sep 30, 2024 by the Defense Health Agency, supports research conducted by The Geneva Foundation to identify functional structural variants that influence therapy outcomes for human castration-resistant prostate cancer. The award is funded through the Military Medical Research and Development program (CFDA 12.420), which supports a broad range of biomedical research initiatives to improve health outcomes for military service members,...
- This Project Grant award in the amount of $325,650.00 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to The Geneva Foundation, a non-profit organization based in Tacoma, Washington. The funding supports an assessment of changes in the human blood proteome following total sleep deprivation over a performance period from March 1, 2025 to February 28, 2027. The Geneva Foundation frequently collaborates with subcontractors such...
- The U.S. Department of Defense's Defense Health Agency awarded a $488,000 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to The Geneva Foundation, a non-profit organization. The grant, awarded on July 1, 2024, supports research to investigate novel mechanisms of regulating the PAX3-FOXO1 fusion oncogene in rhabdomyosarcoma, a type of soft tissue cancer. The research aims to advance treatments for this rare and aggressive form of cancer, with a projected...
- The Defense Health Agency awarded a $410,000 Project Grant titled "Localized and Inflammation-Responsive Immunotherapy of VCA Rejection" to The Geneva Foundation, a 501(c)3 non-profit organization that supports medical research and education for the U.S. military. This grant is part of the "Military Medical Research and Development" program (CFDA 12.420), which funds basic, applied, and advanced biomedical research to transform healthcare for Service Members and the public...